STOCK TITAN

Insider at SOPH (NASDAQ: SOPH) plans 57,001-share Rule 144 sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An insider associated with SOPH has filed a notice of proposed sales under Rule 144 for up to 57,001 shares of common stock, with an indicated aggregate market value of 308,945.42. These shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ, with an approximate sale date of 01/22/2026, and the issuer has 67,847,058 shares outstanding.

The filing shows that 37,001 shares were acquired on 01/22/2026 through an exercise of stock options for cash, and 20,000 founder shares were acquired on 03/18/2021. It also lists a series of prior sales over the past three months under a Rule 10b5-1 trading plan, including individual transactions such as 95,488 shares sold on 01/09/2026 for 491,626.46.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does this Form 144 filing for SOPH represent?

This Form 144 indicates an insider’s intention to sell up to 57,001 shares of SOPH common stock under Rule 144, subject to applicable conditions.

How many SOPH shares are covered by this planned Rule 144 sale?

The notice covers up to 57,001 shares of SOPH common stock, with an indicated aggregate market value of 308,945.42.

How were the SOPH shares to be sold under this Form 144 acquired?

The filing shows 37,001 shares acquired on 01/22/2026 via an exercise of stock options for cash, and 20,000 founder shares acquired on 03/18/2021 from the issuer.

Which broker will handle the SOPH insider’s Rule 144 sale?

The proposed sales are to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ.

How many SOPH shares are outstanding according to this filing?

The notice states that 67,847,058 shares of SOPH common stock are outstanding.

What prior SOPH share sales by this insider are disclosed?

The filing lists multiple Rule 10b5-1 sales of SOPH common stock over the past three months, including a transaction of 95,488 shares on 01/09/2026 for 491,626.46, along with several smaller trades.

What representation does the insider make in this SOPH Form 144?

By signing, the insider represents that they do not know any material adverse nonpublic information about the issuer’s current or prospective operations.

Sophia Genetics Sa

NASDAQ:SOPH

SOPH Rankings

SOPH Latest News

SOPH Latest SEC Filings

SOPH Stock Data

374.52M
63.48M
6.46%
48.2%
0.06%
Health Information Services
Healthcare
Link
Switzerland
Rolle